Protherics Plc - Report of Foreign Issuer (6-K)
June 24 2008 - 2:45PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
24 June 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
Documents lodged with the UK Listing Authority's
Document Viewing Facility
London, UK; Brentwood, TN, US:
24 June
2008
-
Protherics PLC ("Protherics" or the "Company"), the
international biopharmaceutical company focused on critical care and cancer,
announces that the
Company's
Annual Report and Financial Statements for the year ended 31
March 2008
, together with a
Circular to Shareholders containing
the
Notice of the Company's Annual General Meeting to be held at
12.00 noon on Tuesday 22 July 2008 at the offices of Ashurst LLP, Broadwalk House,
5 Appold Street, London EC2A 2HA
,
have
been posted to shareholders
today.
In accordance with
Listing Rule 9.6.1R
the following documents have
been forwarded to the
UK Listing Authority
and will shortly be available for inspection
at
The UK Listing Authority's
Document Viewing Facility,
which is situated at
25 The North Colonnade, Canary Wharf, London E14
5HS:
-
Protherics PLC Annual Report and Financial Statements
f
or the year ended 31 March 2008;
-
Circular to shareholders containing
a
Notice convening the Company's
2008
Annual General Meeting
(the "Meeting")
and
an
explanation of
the
business to be
transacted
at the
Meeting;
-
Copies of the Company's Articles of
Association
which contain
amendments
to be proposed at the Meeting
;
-
Rules of
the Company's
new
2008 Savings Related Share Option Scheme,
which
is
to be submitted to shareholders for
approval
at the Meeting
; and
-
A copy
of
proposed
amendments
to the
Company's
1996 Unapproved Share Option Scheme, which
are to
be submitted to shareholders for approval
at the Meeting
.
A copy of the Company's Annual Report and Financial Statements
can be accessed on the Company's website at
www.protherics.com
.
For further
information
please contact
:
|
|
|
Nick Staples
,
Director of Corporate
Affairs
|
|
Julie Vickers, Company Secretary
|
|
|
|
|
Financial Dynamics
- press enquiries
|
|
London:
Ben Atwell, Lara Mott
|
|
New York
:
John Capodanno,
Jonathan Birt
|
|
Or visi
t
www.protherics.com
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
|
|
Date: 24 June 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
|
Finance Director
|
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
